Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06773845RecruitingPhase 2
Radiation therapy for liver cancer that exceeds up-to-7 criteria
This trial tests a targeted internal radiation treatment for people with liver cancer (HCC) that is too widespread for surgery and goes beyond the up-to-7 criteria. It aims to see if this therapy can safely and effectively treat tumors that are all located in a specific area of the liver.
Gangneung, Gangwon-doAges 19 years+ - NCT06777524Recruiting
Skin-to-skin contact for healthy newborns
This trial looks at how skin-to-skin contact between mother and baby affects healthy newborns. It aims to understand possible health benefits for babies born at full-term and without complications.
Seoul, SeoulAges 1 hour–3 days - NCT06781229Recruiting
Gum bacteria in people preparing for weight loss surgery
This trial looks at the bacteria in the mouths of people with a BMI of 30 or higher who are scheduled for weight-loss surgery. The goal is to understand how gum health and body weight are connected.
ToulouseAges 18 years+ - NCT06774053Recruiting
The SPECTRA study for transgender and gender diverse people
This study follows transgender and gender diverse people of all ages 16 and older to learn more about their health and well-being over time. It is for those who have a diagnosis of gender incongruence and are either starting, continuing, or have stopped gender affirming therapy.
BaselAges 16 years+ - NCT06772675Recruiting
Reducing vancomycin in NICU babies
This study asks NICUs to reduce the use of the antibiotic vancomycin. It's for hospital units that are part of certain networks and agree to follow the study plan.
Modesto, CaliforniaAges 18 years+ - NCT06775782Recruiting
Remote conditioning for moderate stroke from large artery blockage
This trial tests whether a non-invasive arm cuff treatment (remote ischemic conditioning) can help people recover from a moderate stroke caused by a blockage in a major artery. You must start the treatment within 48 hours of your first symptoms.
Xi'an, ShaanxiAges 18–85 - NCT06776510RecruitingPhase 1/Phase 2
NAD for immune thrombocytopenia study
This trial tests if a substance called NAD can help adults with immune thrombocytopenia (ITP) whose platelet levels stay low even after standard treatments. ITP is a condition where the immune system attacks platelets, causing easy bruising and bleeding. The study aims to see if NAD can safely raise platelet counts.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06778824Recruiting
Brain-gut medicine trial for chronic esophagus issues
This trial tests a type of brain-gut medicine to see if it helps with ongoing esophagus problems like heartburn, acid reflux, a lump in the throat, trouble swallowing, or chest pain. It might help if other treatments haven't worked well.
Hualien CityAges 18–75 - NCT06778382RecruitingPhase 2
Delaying treatment after destroying lung spots from colorectal cancer
This trial tests if it's safe to wait before starting full-body therapy after treating a small number of lung tumors (5 or fewer) in people whose colorectal cancer had been gone for at least 6 months. You would first get local treatments like surgery or radiation to destroy the lung spots, then delay additional cancer drugs to see how you do.
Jinan, ShandongAges 18–75 - NCT06778317Recruiting
Blood test to predict liver cancer in cirrhosis patients
This trial tests if a simple blood test can help predict who with cirrhosis might develop liver cancer, so doctors can monitor and treat those patients earlier.
Vandœuvre-lès-NancyAges 18 years+ - NCT06781944RecruitingPhase 3
Obinutuzumab vs standard treatment for membranous nephropathy
This trial tests a new antibody drug (obinutuzumab) against a standard treatment (cyclophosphamide plus steroids) for people with a kidney condition called primary membranous nephropathy that causes protein leakage. The goal is to see which treatment better reduces protein loss and protects kidney function.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06774235RecruitingPhase 3
Interferon gamma to prevent infections in ICU patients
This trial tests if a drug called interferon gamma can help prevent new infections in ICU patients with a weakened immune system. It may help people who have been in the ICU for at least a week and have had multiple organ failure.
AngersAges 18 years+ - NCT06776588Recruiting
Microwave ablation with biopsy for ground-glass lung cancer
This trial tests a treatment that uses heat (microwave ablation) to destroy ground-glass lung nodules while also taking a tissue sample (biopsy) to confirm the diagnosis. It's for people whose lung nodules are 3 cm or smaller and who cannot or choose not to have surgery.
Harbin, HeilongjiangAges 18–75 - NCT06776016RecruitingPhase 2
Dietary supplement for radiation-related rectal injury
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
Guangzhou, GuangdongAges 18–75 - NCT06776861Recruiting
Radiation plus immunotherapy for advanced breast cancer
This study looks at combining radiation therapy with immunotherapy for advanced breast cancer that has spread or cannot be surgically removed. The goal is to see if adding radiation after treatment helps improve outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06777719RecruitingPhase 1
A study of immune cells to prevent kidney rejection
This trial tests if giving you back specially grown immune cells (called Tregs) made from your own blood can help your body accept a new kidney from a living donor with less rejection. It is for people who are ready for a first kidney transplant.
NantesAges 18–99 - NCT06777654Enrolling by invitation
Robotic therapy with mirror therapy for stroke recovery
This study tests if combining robotic therapy with mirror therapy can help improve arm function after a stroke. It is for people who had their first stroke 3 months to 2 years ago and have some but not full arm movement.
TaipeiAges 30–80 - NCT06774924Recruiting
Ultrasound to speed diagnosis in Seine-Saint-Denis
This study tests whether a portable ultrasound device (EchOPen) can help doctors quickly diagnose patients in community clinics and a health bus, connecting them to hospital care. It aims to improve access to fast diagnosis for people in Seine-Saint-Denis.
BondyAges 18 years+ - NCT06776640Recruiting
Vitamin D3 before dental implant surgery for better bone bonding
This trial tests whether taking vitamin D3 pills before and after dental implant surgery helps the implant bond better with the bone. It is for people who have low vitamin D levels and are already scheduled for an implant.
Nantes, NantesAges 18 years+ - NCT04569500Recruiting
Therapy education program for laryngectomy patients and caregivers
This study tests a structured education and support program for people after a total laryngectomy (surgery to remove the voice box) and for their close family caregivers. It aims to improve quality of life for both the patient and the caregiver.
CaenAges 18 years+ - NCT05393518Recruiting
Study linking brain signals to anxiety in people with epilepsy
This study looks at how brain electrical signals relate to anxiety symptoms in people with drug-resistant epilepsy. It compares people who do (or do not) meet criteria for generalized anxiety disorder, to better understand anxiety in this setting.
BordeauxAges 18–65 - NCT06513624RecruitingPhase 1
ETC-159 plus pembrolizumab for advanced ovarian cancer
This trial tests a new combination of two drugs—ETC-159 (a pill that targets a specific growth pathway) and pembrolizumab (an immunotherapy)—for people with advanced ovarian cancer that has stopped responding to platinum chemotherapy. The goal is to see if this combination can help shrink tumors or slow their growth.
Singapore, SingaporeAges 21–99 - NCT04989608Recruiting
Study links brain scan results with thinking after a TIA
This study looks at how brain imaging findings match up with thinking and memory in people after a TIA (a temporary stroke-like event). If you join, your role is mainly to contribute data from brain scans soon after the event, plus study questionnaires.
CaenAges 60 years+ - NCT04852744Recruiting
Brain scan study in teens with borderline and/or PTSD
This study uses brain imaging (MRI) to compare brain patterns in teens with borderline personality disorder and those with PTSD, as well as teens without these mental health diagnoses. It may help researchers understand what brain differences go along with these conditions and how they relate to each other.
CaenAges 13–18
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,157 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.